These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25504371)

  • 1. Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium.
    Youngblood V; Wang S; Song W; Walter D; Hwang Y; Chen J; Brantley-Sieders DM
    Mol Cancer Res; 2015 Mar; 13(3):524-37. PubMed ID: 25504371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.
    Brantley-Sieders DM; Dunaway CM; Rao M; Short S; Hwang Y; Gao Y; Li D; Jiang A; Shyr Y; Wu JY; Chen J
    Cancer Res; 2011 Feb; 71(3):976-87. PubMed ID: 21148069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slit2 suppresses endothelial cell proliferation and migration by inhibiting the VEGF-Notch signaling pathway.
    Li GJ; Yang Y; Yang GK; Wan J; Cui DL; Ma ZH; Du LJ; Zhang GM
    Mol Med Rep; 2017 Apr; 15(4):1981-1988. PubMed ID: 28260032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.
    Dunaway CM; Hwang Y; Lindsley CW; Cook RS; Wu JY; Boothby M; Chen J; Brantley-Sieders DM
    Mol Cell Biol; 2011 Feb; 31(3):404-16. PubMed ID: 21135133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle via reduced eNOS activity.
    Nieminen T; Toivanen PI; Laakkonen JP; Heikura T; Kaikkonen MU; Airenne KJ; Ylä-Herttuala S
    Cardiovasc Res; 2015 Jul; 107(2):267-76. PubMed ID: 26002231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.
    Cheng N; Brantley D; Fang WB; Liu H; Fanslow W; Cerretti DP; Bussell KN; Reith A; Jackson D; Chen J
    Neoplasia; 2003; 5(5):445-56. PubMed ID: 14670182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization.
    Rama N; Dubrac A; Mathivet T; Ní Chárthaigh RA; Genet G; Cristofaro B; Pibouin-Fragner L; Ma L; Eichmann A; Chédotal A
    Nat Med; 2015 May; 21(5):483-91. PubMed ID: 25894826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
    Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
    FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
    Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J
    Oncogene; 2002 Oct; 21(46):7011-26. PubMed ID: 12370823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist.
    Dobrzanski P; Hunter K; Jones-Bolin S; Chang H; Robinson C; Pritchard S; Zhao H; Ruggeri B
    Cancer Res; 2004 Feb; 64(3):910-9. PubMed ID: 14871820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies.
    Li S; Huang L; Sun Y; Bai Y; Yang F; Yu W; Li F; Zhang Q; Wang B; Geng JG; Li X
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5210-7. PubMed ID: 26244297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis.
    Wang LJ; Zhao Y; Han B; Ma YG; Zhang J; Yang DM; Mao JW; Tang FT; Li WD; Yang Y; Wang R; Geng JG
    Cancer Sci; 2008 Mar; 99(3):510-7. PubMed ID: 18201275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of retinal neovascularization by soluble EphA2 receptor.
    Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
    Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.